[1] | Basu A, Jiang X, Negrini M and Haldar S. MicroRNA mediated regulation of pancreatic cancer cell proliferation. Oncology Letters 2010; 1:565-8. |
[2] | Basu A and Haldar S. Antiproliferative and proapoptotic effects of benzyl isothiocyanate on human pancreatic cancer cells is linked to death receptor activation and RasGAP/Rac1 down modulation. Int J Oncol. 2009; 35(3):593-9. |
[3] | Basu A and Haldar S. 2-Methoxyestradiol mediated signaling network in pancreatic cancer. Front Biosci. 2009; 14: 2170-78. |
[4] | Basu A and Haldar S. Combinatorial Effect of Epigallocatechin-3-gallate and TRAIL on Pancreatic Cancer Cell Death. Int J Oncol. 2009; 34(1):281-6. |
[5] | Basu A and Haldar S. Dietary isothiocyanate mediated apoptosis of human cancer cells is associated with Bcl-xL phosphorylation. Int J Oncol. 2008; 33(4):657-63. |
[6] | Basu A, Castle VP, Bouziane M, Bhalla K and Haldar S. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Cancer Res. 2006; 66(8):4309-18. |
[7] | Basu A, DuBois G and Haldar S. Posttranslational modifications of Bcl2 family members--a potential therapeutic target for human malignancy. Front Biosci. 2006; 11:1508-21. |
[8] | Qanungo S, Das M, Haldar S and Basu A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis. 2005; 26(5):958-67. |
[9] | Qanungo, S., Haldar, S. and Basu, A. Restoration of silenced Peutz-Jeghers syndrome gene, LKB1, induces apoptosis in pancreatic carcinoma cells. Neoplasia. 2003; 5(4):367-74. |
[10] | Basu, A. and Haldar, S. Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol-or 2-methoxyestradiol-induced apoptosis. FEBS Lett. 2003;538(1-3):41-7. |
[11] | Basu A and Haldar, S. Signal-induced site specific phosphorylation targets Bcl2 to the proteasome pathway. Int J Oncol. 2002; 21(3):597-601. |
[12] | Qanungo S, Basu A, Das M and Haldar, S. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene. 2002;21(26):4149-57. |
[13] | Basu, A., Das, M., Qanungo, S., Fan, X-U, Dubois, G and Haldar, S. Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation. Neoplasia. 2002;4(3):218-27. |
[14] | Wible, BA., Liming L., Kuryshev, Y., Basu, A., Haldar, S. and Brown AM. Increased K+ efflux and apoptosis induced by the potassium channel modulatory protein KChAP/PIAS3beta in prostate cancer cells. J Biol Chem. 2002; 277(20):17852-62. |
[15] | Pathan, N, Aime-Sempe, C, Kitada, S, Basu, A., Haldar, S, and Reed, JC. Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1. Neoplasia. 2001; 3(6):550-9. |
[16] | Basu, A., You, S-A and Haldar, S. Regulation of Bcl2 phosphorylation by stress response kinase pathway. Int J Oncol. 2000; 16(3):497-500. |
[17] | Basu, A. and Haldar, S. The relationship between BcI2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod. 1998; 4(12):1099-109. Review. |
[18] | You, S-A, Basu, A. and Haldar, S. Potent antitumor agent proteasome inhibitors: a novel trigger for Bcl2 phosphorylation to induce apoptosis. Int J Oncol. 1999; 15(4):625-8. |
[19] | Basu, A. and Haldar, S. Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein. Int J Oncol. 1998;13(4):659-64. |
[20] | Haldar, S., Basu, A. and Croce, C.M. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res. 1998;58(8):1609-15. |
[21] | Carson, W., Fehniger, T.A., Haldar, S., Eckhert, K., Lindemann, M.J., Lai, C.F., Croce, C.M., Baumann H. and Caliguiri, M.A. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest. 1997; 99(5):937-43. |
[22] | Haldar, S., Basu, A. and Croce, C.M. Bcl2 is the guardian of microtubule integrity. Cancer Res. 1997; 57(2):229-33. |
[23] | Haldar, S., Chintapalli, J. and Croce, C.M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 1996;56(6):1253-5. |
[24] | Haldar, S., Jena, N. and Croce, C.M. Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA. 1995; 92(10):4507-11.. |
[25] | Rinaudo MS, Su K, Falk LA, Haldar S and Mufson RA. Human Interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells. Blood 1995; 86(1): 80-8. |
[26] | Haldar, S, Jena, N, Coss, RA, Sedar, AW, Waschsberger, PR, Beatty, C and Croce, CM. Cellular localization of the bcl-2 protein and response to glucocorticoid stress. Cell Death Differ. 1994; 1(2):109-15. |
[27] | Carson, W, Haldar, S., Baiocchi, RA, Croce, CM and Caliguiri, M. The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proc Natl Acad Sci USA. 1994; 91(16):7553-7. |
[28] | Reed JC, Stein C, Subasinghe C, Haldar S., Croce CM, Yum S and Cohen J. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res.1990; 50(20):6565-70. |
[29] | Haldar, S., Jena, N and Croce, CM. Anti-apoptosis potential of BCL2 oncogene by dephosphorylation. Biochemistry & Cell Biology 1994; 72: 455-61. |
[30] | Haldar, S., Jena, N, Dubois, G, Reed, JC, Fu, S. and Croce, CM. Purification and characterization ofthe Bcl2 protein. Arch. Biochem. Biophys. 1994; 315: 483-8. |
[31] | Haldar, S., Jena, N, Coss, RA, Sedar, AW, Waschsberger, PR, Beatty, C and Croce, CM Cellular localization of the Bcl2 protein and response to glucocorticoid stress. Cell Death & Differentiation 1994; 1: 109-115. |
[32] | Haldar, S., Negrini, M, Monne, M, Sabbioni, S and Croce, CM. Down regulation of Bcl2 by p53 in breast cancer cells. Cancer Res. 1994; 54:2095-7. |
[33] | Negrini, M, Sabbioni, S, Haldar, S., Possati, L, Costaggnoli, A, Corallini, A, Barbanti-Brodano, G and Croce, CM. Tumor and growth suppression of breast cancer cells by chromosome 17 associated functions. Cancer Res. 1994; 54:1818-24. |
[34] | Alnemri, ES, Fernandes TF, Haldar, S., Croce, CM and Litwack, G Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res. 1992; 52(2):491-5. |
[35] | Reed JC, Cuddy M, Haldar S, Croce C, Nowell P, Makover D and Bradley K. BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. Proc Natl Acad Sci USA. 1990; 87: 3660-4. |
[36] | Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S and Cohen J. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res. 1990; 50:6565-70. |
[37] | Reed JC, Haldar S, Croce CM and Cuddy MP. Complementation by BCL2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts. Mol Cell Biol. 1990;10:4370-4. |
[38] | Haldar, S., Reed,J.C., Beatty,C. and Croce, C.M. Role of bcl-2 in growth factor triggered signal transduction. Cancer Res. 1990; 50, 7399-7401. |
[39] | Reed, JC, Haldar, S, Cuddy, MP, Croce, CM and Makover, D. Deregulated Bcl2 expression enhances growth of a human B cell line. Oncogene 1989; 4:1123-7. |
[40] | Monroe,J.G. and Haldar, S. Involvement of a specific guanine nucleotide binding protein in receptor immunoglobulin stimulated inositol phospholipid hydrolysis. Biochim.Biophys.Acta, 1989; 1013, 273-8. |
[41] | Marino,T.A., Haldar, S., Williamson,E.C., Beaverson,K., Walter,R.A., Marino,D.R., Beatty,C., and Lipson,K.E. (1991) Proliferating cell nuclear antigen in developing and adult rat cardiac muscle cells. Circ Res 1990; 69, 1353-60. |